2000-2025: Emerging therapies in primary mitochondrial disease: A structured review, horizon scan, and roadmap for the future.

Karaa A, Lopez Sanchez MIG, Stuart C, Bolliger L, Murray K, O'Hanlon ME, Tseng B, Yeske P, Murray S.

Open source

DOI
10.1177/26330040261473291
Published
2026-01-01
Container
Ther Adv Rare Dis
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/26330040261473291,
  title = {2000-2025: Emerging therapies in primary mitochondrial disease: A structured review, horizon scan, and roadmap for the future.},
  author = {Karaa A and  Lopez Sanchez MIG and  Stuart C and  Bolliger L and  Murray K and  O'Hanlon ME and  Tseng B and  Yeske P and  Murray S.},
  year = {2026},
  journal = {Ther Adv Rare Dis},
  doi = {10.1177/26330040261473291},
  url = {https://doi.org/10.1177/26330040261473291}
}

RIS

TY  - JOUR
TI  - 2000-2025: Emerging therapies in primary mitochondrial disease: A structured review, horizon scan, and roadmap for the future.
AU  - Karaa A
AU  -  Lopez Sanchez MIG
AU  -  Stuart C
AU  -  Bolliger L
AU  -  Murray K
AU  -  O'Hanlon ME
AU  -  Tseng B
AU  -  Yeske P
AU  -  Murray S.
PY  - 2026
JO  - Ther Adv Rare Dis
DO  - 10.1177/26330040261473291
UR  - https://doi.org/10.1177/26330040261473291
ER  - 

APA

A, K., MIG, L. S., C, S., L, B., K, M., ME, O., B, T., P, Y., & S., M. (2026). 2000-2025: Emerging therapies in primary mitochondrial disease: A structured review, horizon scan, and roadmap for the future.. Ther Adv Rare Dis. https://doi.org/10.1177/26330040261473291

Source records